Freedom2 Holdings, Inc.

Freedom2 Expands Market Horizons Based on Patented Particle Encapsulation Delivery System

Published in AIDS Weekly, June 23rd, 2008

Freedom2 Holdings, Inc., (Freedom-2, Inc.'s holding company), pioneers in the development of safe, quality inks for the purpose of permanent but more easily removable tattoos announces its expansion into the two-hundred and fifty billion dollar worldwide skin care industry through the application of the company's Patented Particle Encapsulation Delivery System (PEDS).

PEDS, the result of seminal discoveries from prominent research physicians and scientists, allows the safe encapsulation of dyes, pigments and active pharmaceuticals to the skin, through the skin or under the skin. Freedom-2's product pipeline includes aesthetic, cosmetic and therapeutic solutions.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2008-06-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry